IDI1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.208610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.029400E-01
Normal-vs-Stage2
1.074770E-01
Normal-vs-Stage3
6.156500E-02
Normal-vs-Stage4
9.858000E-01
Stage1-vs-Stage2
3.843200E-01
Stage1-vs-Stage3
2.526200E-01
Stage1-vs-Stage4
5.578400E-01
Stage2-vs-Stage3
2.802000E-01
Stage2-vs-Stage4
3.690400E-01
Stage3-vs-Stage4
1.852370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.440380E-01
Normal-vs-AfricanAmerican
1.990390E-01
Normal-vs-Asian
1.289920E-02
Caucasian-vs-AfricanAmerican
7.887600E-01
Caucasian-vs-Asian
2.739800E-01
AfricanAmerican-vs-Asian
2.101000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.005600E-01
Normal-vs-Female
4.733900E-02
Male-vs-Female
3.943200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.911380E-01
Normal-vs-Age(41-60Yrs)
1.072580E-01
Normal-vs-Age(61-80Yrs)
1.449410E-01
Normal-vs-Age(81-100Yrs)
1.384170E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.080600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.755400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.293000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.711600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.942600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.269400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.797000E-01
Normal-vs-Daily Drinker
1.127840E-01
Normal-vs-Weekly Drinker
3.116900E-03
Normal-vs-Occasional Drinker
1.752230E-01
Normal-vs-Social Drinker
1.215270E-03
Non Drinker-vs-Daily Drinker
4.300600E-01
Non Drinker-vs-Weekly Drinker
5.492400E-02
Non Drinker-vs-Occasional Drinker
5.565600E-01
Non Drinker-vs-Social Drinker
3.276000E-02
Daily Drinker-vs-Weekly Drinker
2.480400E-01
Daily Drinker-vs-Occasional Drinker
8.859400E-01
Daily Drinker-vs-Social Drinker
1.634580E-01
Weekly Drinker-vs-Occasional Drinker
2.504600E-01
Weekly Drinker-vs-Social Drinker
7.937200E-01
Occasional Drinker-vs-Social Drinker
1.790990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.862100E-02
Normal-vs-Grade 2
8.420100E-02
Normal-vs-Grade 3
7.772300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.795400E-01
Grade 1-vs-Grade 3
4.489600E-01
Grade 1-vs-Grade 4
8.862100E-02
Grade 2-vs-Grade 3
3.540300E-02
Grade 2-vs-Grade 4
8.420100E-02
Grade 3-vs-Grade 4
7.772300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.264410E-01
Normal-vs-NonDiabetic
1.048560E-01
Diabetic-vs-NonDiabetic
9.938000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.981600E-01
Normal-vs-NoPancreatitis
1.037950E-01
Pancreatitis-vs-NoPancreatitis
6.762400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.076800E-01
Normal-vs-N1
1.027430E-01
N0-vs-N1
1.047350E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.234000E-01
Normal-vs-TP53-NonMutant
2.043400E-01
TP53-Mutant-vs-TP53-NonMutant
3.914600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
